Device Trial Radar · NCT03584295
Early Extubation by ECCO2R Compared to IMV in Patients with Severe Acute Exacerbation of COPD
Last checked: Nov 20, 2026Latest source record: Mar 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
18
Actual
Start
Feb 7, 2023
Primary completion
Nov 1, 2024
Study completion Nov 25, 2024
Sponsor
- Lead sponsor
- Xenios AGNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Winicker Norimed GmbH
- First posted
- Jul 12, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study aims to investigate if veno-venous (vv)-extracorporeal carbon dioxide Removal (ECCO2R) is capable of reducing mortality and/or severe disability at day 60 after randomisation in patients with severe acute exacerbation of chronic obstructive pulmonary disease (COPD) requiring invasive mechanical ventilation (IMV). Extubation will be facilitated by VV-ECCO2R and compared to IMV alone in a randomized controlled trial.
Conditions
- COPD Exacerbation
Interventions
Extracorporeal carbon dioxide removalDevice
Patients with acute exacerbation of severe COPD, requiring invasive mechanical ventilation will be treated with vv-ECCO2R to facilitate early extubation
Conventional CareOther
Patient with acute exacerbation of severe COPD, requiring invasive mechanical ventilation treated with Conventional Care. Conventional care includes invasive mechanical ventilation and the attempt to extubate the patient and switch to NIV. If extubation fails tracheostomy can be performed according to the treating physician.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Death or severe disabilityTime frame: day 60
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Kliniken der Stadt Köln gGmbH, ARDS and ECMO Zentrum Köln-Merheim
Cologne, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.